Free Trial
OTCMKTS:BNXTF

BioNxt Solutions (BNXTF) Stock Price, News & Analysis

BioNxt Solutions logo
$0.35 +0.08 (+32.33%)
As of 03:09 PM Eastern

About BioNxt Solutions Stock (OTCMKTS:BNXTF)

Key Stats

Today's Range
$0.35
$0.35
50-Day Range
$0.26
$0.43
52-Week Range
$0.11
$0.43
Volume
550 shs
Average Volume
9,940 shs
Market Capitalization
$40.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Receive BNXTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioNxt Solutions and its competitors with MarketBeat's FREE daily newsletter.

BNXTF Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

BNXTF Stock Analysis - Frequently Asked Questions

BioNxt Solutions' stock was trading at $0.2519 at the beginning of the year. Since then, BNXTF stock has increased by 37.3% and is now trading at $0.3459.
View the best growth stocks for 2025 here
.

BioNxt Solutions Inc. (OTCMKTS:BNXTF) released its quarterly earnings data on Friday, November, 29th. The company reported ($0.01) earnings per share for the quarter.

Shares of BNXTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/29/2024
Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BNXTF
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,720,000.00
Net Margins
-15,638.71%
Pretax Margin
-15,380.65%

Debt

Sales & Book Value

Annual Sales
$280,000.00
Price / Cash Flow
N/A
Book Value
($0.04) per share
Price / Book
-8.65

Miscellaneous

Free Float
N/A
Market Cap
$40.04 million
Optionable
Not Optionable
Beta
0.56
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:BNXTF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners